WO2024157194 - METHODS AND ASSAYS FOR OFF-TARGET ANALYSIS
National phase entry is expected:
Publication Number
WO/2024/157194
Publication Date
02.08.2024
International Application No.
PCT/IB2024/050681
International Filing Date
25.01.2024
Title **
[English]
METHODS AND ASSAYS FOR OFF-TARGET ANALYSIS
[French]
PROCÉDÉS ET DOSAGES POUR ANALYSE HORS CIBLE
Applicants **
CRISPR THERAPEUTICS AG
Baarerstrasse 14
6300 Zug, CH
Inventors
CHAUDHARI,, Hemangi
105 West First Street
South Boston, Massachusetts 02127, US
PENTERMAN, Jon
105 West First Street
South Boston, Massachusetts 02127, US
KULMAN, John
105 West First Street
South Boston, Massachusetts 02127, US
Priority Data
63/481,529
25.01.2023
US
63/481,547
25.01.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 3094 | |
| EPO | Filing, Examination | 30019 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 13285 |
Total: 47594 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure provides methods, assays, nucleic acid libraries, compositions, kits and systems for assessing RNA-guided endonucleases including their on-target and/or off-target activities, and for generating off-target profiles for RNA-guided endonucleases.[French]
La présente invention concerne des procédés, des dosages, des banques d'acides nucléiques, des compositions, des kits et des systèmes permettant d'évaluer les endonucléases guidées par l'ARN, y compris leurs activités sur cible et/ou hors cible, et de générer des profils hors cible pour les endonucléases guidées par ARN.